Cenegermin Ophthalmic Solution [Oxervate]
RxNorm 2104339
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 2104339 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: cenegermin Ophthalmic Solution [Oxervate].
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SBDFPrescribable
Semantic Branded Drug Form (SBDF):
Cenegermin Ophthalmic Solution [Oxervate]
(Atom ID: 12323473)
Patient Education
Cenegermin-bkbj Ophthalmic
Ophthalmic cenegermin-bkbj is used to treat neurotrophic keratitis (a degenerative eye disease that can lead to damage of the cornea [the outermost layer of the eye]). Cenegermin-bkbj is in a class of medications called recombinant human nerve growth factors. It works to heal the cornea.
[Learn More]
* Please review the disclaimer below.